Julian Baker, 10% Owner at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 3,645,600 shares at $5.00 ($18.3M) on 2016-08-12, disclosed to the SEC on 2016-08-16.
Open-market sale of $18.3M BCRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 465,439 | $2.3M | 12.7% |
| 2 | $5.00 | 2,834,561 | $14.2M | 77.4% |
| 3 | $5.25 | 48,744 | $256K | 1.4% |
| 4 | $5.25 | 296,856 | $1.6M | 8.5% |
| Total | $5.02 avg | 3,645,600 | $18.3M | 100% |
| Filing → |
| MDGL | BUY | 2023-11-15 | $15.6M | — | Filing → |
| BCEL | SELL | 2023-10-23 | $211K | — | Filing → |
| IGMS | BUY | 2023-06-28 | $45.0M | — | Filing → |